Concepedia

Publication | Closed Access

Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study

DOI

17

Citations

5

References

2022

Year

Jérôme Hadjadj, Alice Canzian, Ömer Karadağ, A. Contis, F. Maurier, Sébastien Sanges, Silvia Sartorelli, Laure Denis, Claire de Moreuil, Cécile‐Audrey Durel,
Lara D. Veeken

Abstract

These results suggest that TCZ may be effective in relapsing and/or refractory PAN. Our data warrant further study to confirm these findings.

References

YearCitations

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. Charles Jennette, Ronald J. Falk, P. A. Bacon,

Arthritis & Rheumatism

2012

6.4K

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

Chetan Mukhtyar, R Lee, Denise Scott Brown,

Annals of the Rheumatic Diseases

2008

1.2K

The Five-Factor Score Revisited

Christian Pagnoux, Raphaèle Séror, Alfred Mahr,

Medicine

2010

911

Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

Xavier Puéchal, Christian Pagnoux, Gabriel Baron,

Arthritis & Rheumatology

2017

164

Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.

M. Samson, Xavier Puéchal, Luc Mouthon,

PubMed

2017

31

Page 1